Metastatic uveal melanoma therapeutics market is anticipated to grow at a significant CAGR during the forecast period. Uveal melanoma is a rare intraocular tumor in adults which originates in either iris, ciliary body, or choroid. Around 50% of the people develop metastatic disease after uveal melanoma diagnosis. It metastasizes to the liver and carries poor prognosis. The market growth is attributed to the increasing prevalence of uveal melanoma cancer all over the globe. Since the drugs used for metastatic uveal melanoma providing ample growth opportunities, the market players are constantly focusing on developing advanced solutions to treat the disease. Various types of therapeutics used to treat metastatic uveal melanoma include sunitinib malate, vincristine sulphate liposomal, ly-2801653, and sotrastaurin acetate among others.
The increasing geriatric population across the globe is also likely to propel the market growth during the forecast period. Elderly population is more prone to develop eye related medical issues. In fact, the prevalence of intraocular tumor in elderly population is comparatively higher owing to the wide prevalence of cataract among them. As per the National Center for Biotechnology Information (NCBI), uveal melanoma is a rare cancer, however, the most frequent include noncutaneous melanoma and primary malignancy of the eye in adults. Globally, it is estimated that there are 7,095 new cases of uveal melanoma annually with a mean age-adjusted incidence of 4.3 per million. All these factors lead to the growing demand for therapeutics solutions such as metastatic uveal melanoma therapeutics.
To Request a Sample of our Report on Metastatic Uveal Melanoma Therapeutics Market: https://www.omrglobal.com/request-sample/metastatic-uveal-melanoma-therapeutics-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: AstraZeneca plc, Eli Lilly and Co., and Novartis International AG, among others.
Metastatic Uveal Melanoma Therapeutics Market Report by Segment
By Type
- Sunitinib Malate
- Vincristine Sulfate Liposomal
- LY-2801653
- Sotrastaurin Acetate
- Others
By Application
- Hospital
- Clinic
- Others
A full Report of Metastatic Uveal Melanoma Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/metastatic-uveal-melanoma-therapeutics-market
Metastatic Uveal Melanoma Therapeutics Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404